Voloridge Investment Management
BNTX icon

Voloridge Investment Management’s BioNTech BNTX Stock Holding History

Voloridge Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7M Sell
243,422
-64,442
-21% -$6.06M 0.1% 282
2026
Q1 		$27.4M Sell
307,864
-129,701
-30% -$13.3M 0.11% 264
2025
Q4 		$41.7M Buy
+437,565
New +$44.1M 0.15% 178
2025
Q3 		– Sell
-237,732
Closed -$25.3M – 1191
2025
Q2 		$25.3M Sell
237,732
-145,247
-38% -$14.7M 0.09% 273
2025
Q1 		$34.9M Buy
382,979
+31,884
+9% +$3.57M 0.13% 214
2024
Q4 		$40M Sell
351,095
-49,211
-12% -$5.62M 0.14% 201
2024
Q3 		$47.5M Buy
400,306
+130,449
+48% +$12M 0.17% 170
2024
Q2 		$21.7M Sell
269,857
-328,910
-55% -$30.1M 0.08% 336
2024
Q1 		$55.2M Buy
598,767
+16,202
+3% +$1.55M 0.2% 139
2023
Q4 		$61.5M Buy
582,565
+52,051
+10% +$5.25M 0.24% 116
2023
Q3 		$57.6M Buy
530,514
+338,973
+177% +$37.5M 0.28% 87
2023
Q2 		$20.7M Buy
191,541
+181,832
+1,873% +$20.5M 0.1% 279
2023
Q1 		$1.21M Sell
9,709
-46,436
-83% -$6.38M 0.01% 1089
2022
Q4 		$8.43M Buy
56,145
+33,563
+149% +$5.16M 0.05% 479
2022
Q3 		$3.05M Sell
22,582
-40,633
-64% -$6.21M 0.02% 839
2022
Q2 		$9.43M Buy
+63,215
New +$9.66M 0.05% 461
2021
Q4 		– Sell
-77,409
Closed -$21.1M – 1585
2021
Q3 		$21.1M Sell
77,409
-60,104
-44% -$19.1M 0.14% 198
2021
Q2 		$30.8M Buy
+137,513
New +$25.9M 0.21% 112
2021
Q1 		– Sell
-135,947
Closed -$11.1M – 1402
2020
Q4 		$11.1M Buy
+135,947
New +$13.3M 0.09% 253

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Voloridge Investment Management's BNTX Position: Q2 2026 in Review

Voloridge Investment Management reduced its BioNTech (BNTX) stake by 21% in Q2 2026, selling an estimated $6.06M and leaving 243,422 shares worth $22.7M. The position accounts for 0.1% of the portfolio, ranked #282.

Voloridge Investment Management first reported a position in BNTX in Q4 2020 and has held it in 19 quarters since. The position peaked at $61.5M in Q4 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Voloridge Investment Management held 243,422 shares of BioNTech worth $22.7M as of Q2 2026.
  • Voloridge Investment Management sold 64,442 BioNTech shares in Q2 2026, an estimated $6.06M.
  • BioNTech made up 0.1% of Voloridge Investment Management's portfolio in Q2 2026, its #282 holding.
  • Voloridge Investment Management first reported a position in BioNTech in Q4 2020 and has held it in 19 quarters since.
  • Voloridge Investment Management's BioNTech position peaked at $61.5M in Q4 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.